About Natera, Inc.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.
2BB score and signals
Natera, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 72 | High |
| Momentum | 55 | Stable |
| Financial strength | 45 | Normal |
| Quality | 100 | Very Strong |
| Risk | 34 | Low |
Company facts
| CEO | Steven Chapman |
| Headquarters | Austin, Texas, United States |
| Founded | Jan 1, 2004 |
| Employees | 6.14K |
| 52-week range | $157.42 – $343.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.042 | — | $762.10M |
| 2026-11-04 | — | -0.248 | — | $718.71M |
| 2026-08-06 | — | -0.5036 | — | $673.90M |
| 2026-05-07 | -0.6 | -0.5471 | $696.64M | $629.45M |
Related companies
